Retrospective audit of continuous lignocaine for TCell Lymphoma

This retrospective audit examines clinical experience with subcutaneous lignocaine over a ten-year period, in the management of intractable pruritus associated with mycoses fungoides/T cell lymphoma at Peter MacCallum Cancer Centre. The audit will include 19 patients treated with continuous infusions of subcutaneous lignocaine, to assess response, side effects, effective dose, and duration of response


  • Peter MacCallum Cancer Centre 

Principal investigator 

  • Associate Professor Odette Spruyt - Palliative care consultant 


Associate Professor Odette Spruyt - Principal Investigator 

  • Email: This email address is being protected from spambots. You need JavaScript enabled to view it.